Sara De Dosso, Deputy Head of Medical Oncology and Head of Gastrointestinal Cancer Unit at Oncology Institute of Southern Switzerland, shared a post on LinkedIn:
“Another edition of ESMOGI26 has come to an end, reaffirming once again the extraordinary energy, collaboration, and innovation that drive the global gastrointestinal Oncology Community.
It was a great honor to actively contribute to the success of this outstanding meeting.
I was also pleased to present the preliminary results of our FusoMetro-001 study, exploring GutMicrobiota modulation in colorectal cancer.
Always proud to represent IOSI Istituto Oncologico della Svizzera Italiana – EOC on this international stage.”
Other articles about ESMOGI26 on OncoDaily.
